Enquire now in case of any assistance needed

Drug Eluded Stent Treatment Cost in India

  • Starting From: USD 84 - USD 421

How Much Does Drug Eluded Stent Treatment Cost in India?

Drug Eluded Stent is affordable in India. The cost of Drug Eluded Stent in India lies between USD 84 - USD 421. The exact procedure price depends on multiple factors such as the surgeon's experience, type of hospital, severity of the condition, patient's general condition,etc.

Get Your Drug Eluded Stent Treatment Cost in India

Leading Hospitals for Drug Eluded Stent in India

Choose Your Preferred City

The CT stent, or drug-eluting stent, stands as a testament to the constant innovation in cardiovascular medicine. This remarkable device has revolutionized the treatment of coronary artery disease (CAD), offering a minimally invasive solution for patients with narrowed or blocked arteries. Through its ingenious design and drug-eluting capabilities, the CT stent provides a targeted approach to restore blood flow and alleviate symptoms. This article delves into the intricate world of CT stents, covering their composition, deployment, benefits, considerations, and the evolution of this groundbreaking technology.

Understanding Coronary Artery Disease (CAD)

Coronary artery disease is a condition characterized by the narrowing or blockage of coronary arteries, which supply the heart muscle with oxygenated blood. This narrowing, typically due to the buildup of fatty deposits called plaque, can lead to symptoms such as chest pain (angina) and, in severe cases, heart attacks.

The Evolution of Stents

Early stents were typically made of metal mesh and served as scaffolding to keep arteries open after angioplasty, a procedure that uses a balloon to widen the narrowed artery. While effective, these stents had limitations, including a tendency for the artery to re-narrow (restenosis) and the need for repeat procedures.

Introduction of Drug-Eluting Stents

The advent of drug-eluting stents marked a significant advancement in interventional cardiology. These stents are coated with a thin layer of medication that is slowly released over time, preventing restenosis by inhibiting the growth of cells that cause the artery to narrow again.

Composition of Drug-Eluting Stents

Drug-eluting stents typically consist of three key components:

  • Stent Scaffold: Usually made of a metal alloy such as stainless steel, cobalt-chromium, or platinum-chromium, the stent provides structural support to the artery.
  • Polymer Coating: This thin layer of biocompatible polymer is applied to the stent's surface. It serves as a carrier for the drug and helps control the release rate.
  • Drug: The drug, often an anti-proliferative or anti-inflammatory agent, is embedded in the polymer coating. Common drugs used include sirolimus, everolimus, or paclitaxel.

Deployment of CT Stents

  • Preparation: Before the stent is placed, the narrowed artery is typically treated with angioplasty. A deflated balloon catheter is threaded to the site of the blockage and inflated, compressing the plaque against the artery walls.
  • Stent Placement: The drug-eluting stent, mounted on a balloon catheter, is positioned within the artery at the site of the blockage. The balloon is then inflated, expanding the stent and pushing it against the artery walls.
  • Drug Release: Once in place, the drug-eluting stent begins to release the medication. This controlled release inhibits the proliferation of cells that could lead to restenosis.

Benefits of CT Stents

  • Reduced Restenosis: The drug-eluting properties of CT stents significantly reduce the risk of restenosis compared to earlier bare-metal stents.
  • Preservation of Vessel Size: CT stents help maintain the size of the treated vessel, crucial for maintaining proper blood flow.
  • Improved Long-Term Outcomes: Studies have shown that patients treated with drug-eluting stents experience better long-term outcomes, with lower rates of repeat procedures.
  • Decreased Need for Multiple Interventions: The use of CT stents can often reduce the need for repeat procedures, leading to improved quality of life for patients.

Considerations for Patients with CT Stents

  • Dual Antiplatelet Therapy (DAPT): Patients with drug-eluting stents are typically prescribed DAPT, a combination of aspirin and a P2Y12 inhibitor, for a specified period to prevent blood clots around the stent.
  • Regular Follow-Up: Close monitoring by a cardiologist is essential to assess the stent's performance and overall cardiac health.
  • Lifestyle Modifications: Adopting a heart-healthy lifestyle, including a balanced diet, regular exercise, smoking cessation, and stress management, is crucial for long-term success.
  • Potential Complications: While rare, complications can include stent thrombosis (blood clot in the stent), in-stent restenosis, or allergic reactions to the stent materials.

The Future of CT Stents

Ongoing research and development in interventional cardiology continue to refine and enhance the capabilities of drug-eluting stents. Innovations may include improved drug formulations, biodegradable polymers, and advances in stent design to further optimize patient outcomes.

Outlook

The CT stent stands as a testament to the remarkable progress in cardiovascular medicine, offering a targeted and effective solution for individuals with coronary artery disease. Through its ingenious design, drug-eluting capabilities, and precise deployment, this device has transformed the landscape of interventional cardiology. By alleviating symptoms, reducing restenosis, and improving long-term outcomes, the CT stent exemplifies the pioneering spirit of medical science. It continues to pave the way for innovative approaches in the treatment of coronary artery disease, promising renewed hope and vitality for patients around the world.
 

Author

Doctor of Pharmacy
Dr. Deepanshu Siwach is a skilled clinical pharmacist with a Doctor of Pharmacy degree. He has 4+ years of experience and has worked with thousands of patients. He has been associated with some of the top hospitals, such as Artemis Gurgaon.

View Profile

Dr. Deepanshu Siwach is a skilled clinical pharmacist with a Doctor of Pharmacy degree. He has 4+ years of experience and has worked with thousands of patients. He has been associated with some of the top hospitals, such as Artemis Gurgaon....

Reviewer

Chairman
Cardiac Electrophysiologist, Interventional Cardiologist

BLK-Max Super Speciality Hospital, New Delhi

Dr. T. S. Kler is a Padma Bhushan recipient with over 48 years of experience as an Interventional Cardiologist and Electrophysiologist. He has performed over 35,000 angioplasties and is a pioneer in electrophysiology, having established the first department in India. ...

Blogs

The Art of Effective Communication